Abstract
DNA interstrand crosslinks (ICLs) can be induced by numerous endogenous and exogenous chemical agents with the capacity of covalently binding to two base sites in the two strands of the DNA duplex. A series of normal DNA metabolism processes are affected by ICLs. For example, DNA replication and transcription are interfered during cell division, which is fatal to cell survival. In cancer cells, the induction of ICLs is a significant target for cancer chemotherapies. However, the formation of ICLs in cancer cells can be weakened by the repair mechanisms of DNA damage, which results in resistance to chemotherapies. Therefore, it is necessary to develop highly effective ICL agents for the purpose of achieving good chemotherapeutic effects. Furthermore, the combination of ICL agents with inhibitors of ICL repair is a promising strategy for the clinical treatment of cancer. This review summarizes the development of several types of ICL agents as chemotherapies over the past decades and the mechanisms underlying the repair of DNA ICLs. The potential of ICL repair inhibitors for combination therapy with ICL agents in cancer treatment is also discussed.
Keywords: Anticancer efficiency, combination chemotherapy, cytotoxicity, DNA interstrand crosslinks, inhibitors, repair mechanism.
Anti-Cancer Agents in Medicinal Chemistry
Title:The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy
Volume: 16 Issue: 2
Author(s): Sun Guohui, Zhao Lijiao and Zhong Rugang
Affiliation:
Keywords: Anticancer efficiency, combination chemotherapy, cytotoxicity, DNA interstrand crosslinks, inhibitors, repair mechanism.
Abstract: DNA interstrand crosslinks (ICLs) can be induced by numerous endogenous and exogenous chemical agents with the capacity of covalently binding to two base sites in the two strands of the DNA duplex. A series of normal DNA metabolism processes are affected by ICLs. For example, DNA replication and transcription are interfered during cell division, which is fatal to cell survival. In cancer cells, the induction of ICLs is a significant target for cancer chemotherapies. However, the formation of ICLs in cancer cells can be weakened by the repair mechanisms of DNA damage, which results in resistance to chemotherapies. Therefore, it is necessary to develop highly effective ICL agents for the purpose of achieving good chemotherapeutic effects. Furthermore, the combination of ICL agents with inhibitors of ICL repair is a promising strategy for the clinical treatment of cancer. This review summarizes the development of several types of ICL agents as chemotherapies over the past decades and the mechanisms underlying the repair of DNA ICLs. The potential of ICL repair inhibitors for combination therapy with ICL agents in cancer treatment is also discussed.
Export Options
About this article
Cite this article as:
Guohui Sun, Lijiao Zhao and Rugang Zhong, The Induction and Repair of DNA Interstrand Crosslinks and Implications in Cancer Chemotherapy , Anti-Cancer Agents in Medicinal Chemistry 2016; 16 (2) . https://dx.doi.org/10.2174/1871520615666150824160421
DOI https://dx.doi.org/10.2174/1871520615666150824160421 |
Print ISSN 1871-5206 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5992 |
Call for Papers in Thematic Issues
Advances in Nanomedicines and Targeted Therapies for Colorectal Cancer
Colorectal cancer remains a significant global health challenge, with high incidence and mortality rates despite advancements in treatment strategies. Conventional therapies often face limitations such as systemic toxicity, drug resistance, and suboptimal targeting. The advent of nanomedicines and innovative drug delivery systems offers new hope for overcoming these challenges and ...read more
Discovery of Lead compounds targeting transcriptional regulation
Transcriptional regulation plays key physiological functions in body growth and development. Transcriptional dysregulation is one of the important biomarkers of tumor genesis and progression, which is involved in regulating tumor cell processes such as cell proliferation, differentiation, and apoptosis. Additionally, it plays a pivotal role in angiogenesis and promotes tumor ...read more
Induction of cell death in cancer cells by modulating telomerase activity using small molecule drugs
Telomeres are distinctive but short stretches present at the corners of chromosomes that aid in stabilizing chromosomal makeup. The resynthesis of telomeres is supported by the activity of reverse transcriptase ribonucleoprotein complex telomerase. There is no telomerase activity in human somatic cells, but the stem cells and germ cells undergo ...read more
Innovative targets in medicinal chemistry
Medicinal chemistry continuously evolves in response to emerging healthcare needs and advancements in scientific understanding. This special issue explores the current landscape of innovative targets in medicinal chemistry, highlighting the quest for novel therapeutic avenues. From traditional drug targets such as enzymes and receptors to emerging targets like protein-protein interactions ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Matrix Metalloproteinase Inhibitor MMI-166 Suppresses the Growth of SW1990 Human Pancreatic Cancer Cells
Current Signal Transduction Therapy Peptide Nucleic Acids with a Structurally Biased Backbone: Effects of Conformational Constraints and Stereochemistry
Current Topics in Medicinal Chemistry Identification of Flavonoids by LC-MS/MS in Leaves Extract From <i>Protium heptaphyllum</i> (Aubl.) March and Antioxidant Activity in Mice
The Natural Products Journal The Urokinase Plasminogen Activator System: A Target for Anti-Cancer Therapy
Current Cancer Drug Targets Advances in Translational Pharmacological Investigations in Identifying and Validating Molecular Targets of Natural Product Anticancer Agents
Current Cancer Drug Targets Anthocyanins As Modulators of Cell Redox-Dependent Pathways in Non-Communicable Diseases
Current Medicinal Chemistry Anionic Host Defence Peptides from the Plant Kingdom: Their Anticancer Activity and Mechanisms of Action
Protein & Peptide Letters Proteasome Inhibitors in Cancer Therapy
Current Drug Targets Polarized Angular Dependent Light Scattering Properties of Bare and PEGylated Gold Nanoshells
Current Nanoscience 4-Hydroxy-3-methoxyphenyl Substituted 3-methyl-tetrahydroquinoline Derivatives Obtained Through Imino Diels-Alder Reactions as Potential Antitumoral Agents
Letters in Drug Design & Discovery A Recent Advancement in Nanotechnology Approaches for the Treatment of Cervical Cancer
Anti-Cancer Agents in Medicinal Chemistry Pore-Forming Proteins and their Application in Biotechnology
Current Pharmaceutical Biotechnology Recent Developments Towards Podophyllotoxin Congeners as Potential Apoptosis Inducers
Anti-Cancer Agents in Medicinal Chemistry Regulative Roles of Ghrelin in Ingestive Behavior, Upper Gastrointestinal Motility, and Secretion
Current Nutrition & Food Science Oncogenic LncRNA CASC9 in Cancer Progression
Current Pharmaceutical Design Anti-Cancerous Effect of Rutin Against HPV-C33A Cervical Cancer Cells via G0/G1 Cell Cycle Arrest and Apoptotic Induction
Endocrine, Metabolic & Immune Disorders - Drug Targets Synthesis of New N1Arylpiperazine Substituted Xanthine Derivatives and Evaluation of their Antioxidant and Cytotoxic Effects
Anti-Cancer Agents in Medicinal Chemistry Allergy and Inflammation: An Immunological and Therapeutic Approach
Recent Patents on Inflammation & Allergy Drug Discovery Four Major Factors Regulate Phosphatidylinositol 3-kinase Signaling Pathway in Cancers Induced by Infection of Human Papillomaviruses
Current Medicinal Chemistry Molecules of Natural Origin, Semi-synthesis and Synthesis with Anti-Inflammatory and Anticancer Utilities
Current Pharmaceutical Design